-
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Analysts
Source: Buzz FX / 06 Nov 2024 03:36:17 America/New_York
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat November 6, 2024 Share Link copied to clipboard. Enanta Pharmaceuticals, Inc. ( NASDAQ:ENTA - Get Free Report ) has been g
Read more...